ANEBULO PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01. Other Events.

On January 3, 2022, Anebulo Pharmaceuticals, Inc. issued a press release titled "Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication." A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference into this current report.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The exhibit listed in the following Exhibit Index is filed as part of this current report.

Exhibit
Number                              Exhibit Description

            Press release issued by Anebulo Pharmaceuticals, Inc. on January 3,
99.1      2022  .
          Cover Page Interactive Data File (embedded within the Inline XBRL
104       document)




2

© Edgar Online, source Glimpses